FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232 | -92.8% | 109,219 | -83.8% | 0.00% | -100.0% |
| Q2 2023 | $3,200 | -57.9% | 672,316 | -49.6% | 0.01% | -50.0% |
| Q1 2023 | $7,598 | -58.3% | 1,332,919 | -26.2% | 0.01% | -60.0% |
| Q4 2022 | $18,212 | -99.8% | 1,804,936 | +235.8% | 0.02% | +47.1% |
| Q3 2022 | $12,046,000 | +585.6% | 537,519 | +1086.1% | 0.02% | +750.0% |
| Q1 2022 | $1,757,000 | -41.7% | 45,319 | +30.5% | 0.00% | -50.0% |
| Q2 2021 | $3,013,000 | +46.0% | 34,719 | -32.7% | 0.00% | +100.0% |
| Q3 2020 | $2,063,000 | +759.6% | 51,619 | +336.7% | 0.00% | – |
| Q2 2019 | $240,000 | -82.9% | 11,819 | -85.2% | 0.00% | -100.0% |
| Q1 2019 | $1,400,000 | -9.6% | 79,662 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $1,549,000 | +296.2% | 95,100 | +137.2% | 0.00% | – |
| Q2 2018 | $391,000 | 0.0% | 40,100 | 0.0% | 0.00% | – |
| Q1 2018 | $391,000 | -55.9% | 40,100 | -72.4% | 0.00% | -100.0% |
| Q4 2017 | $887,000 | +1.8% | 145,200 | -34.0% | 0.00% | 0.0% |
| Q3 2017 | $871,000 | -13.0% | 219,900 | -28.8% | 0.00% | 0.0% |
| Q2 2017 | $1,001,000 | -25.6% | 308,800 | +4.4% | 0.00% | -50.0% |
| Q1 2017 | $1,345,000 | +155.2% | 295,700 | +40.9% | 0.00% | +100.0% |
| Q4 2016 | $527,000 | -10.2% | 209,900 | +11.6% | 0.00% | 0.0% |
| Q3 2016 | $587,000 | +91.2% | 188,000 | +4.0% | 0.00% | 0.0% |
| Q2 2016 | $307,000 | -23.4% | 180,700 | -18.9% | 0.00% | 0.0% |
| Q1 2016 | $401,000 | +34.6% | 222,700 | +151.6% | 0.00% | 0.0% |
| Q4 2015 | $298,000 | -39.7% | 88,500 | -4.4% | 0.00% | 0.0% |
| Q3 2015 | $494,000 | -5.4% | 92,600 | +14.7% | 0.00% | 0.0% |
| Q2 2015 | $522,000 | +615.1% | 80,720 | +441.7% | 0.00% | – |
| Q1 2015 | $73,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |